American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Lucid Diagnostics Inc. (LUCD)

$0.41 +25.42% NASDAQ: LUCD · 15-min delayed

NEW YORK, New York
Public · NASDAQ: LUCD
82 employees

Visit website Follow

$173.1MMarket cap

$4.3MRevenue · FY2024

-$58.0MNet income

82Employees

LUCDNASDAQ

2021IPO

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: LUCD
Employees: 82
IPO date: Oct 14, 2021
Headquarters: 360 MADISON AVENUE
NEW YORK, New York 10017
Phone: 212 949 4319
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: LUCD Nasdaq
SEC CIK: 1799011
EIN: 825488042
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Lucid Diagnostics Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/lucid-diagnostics-inc/"><img src="https://americancompanies.com/badge/lucid-diagnostics-inc.svg" alt="Lucid Diagnostics Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Lucid Diagnostics Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2024: $4.3M
Net income: -$58.0M
Total assets: $40.4M
Market cap: $173.1M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: LUCD

$0.41 +25.42%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.33 $1.47

52-week range

Market cap: $173.1M
Shares outstanding: 422.3M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Oct 14, 2021

Lucid Diagnostics Inc. (LUCD) Stock Price

Reported a net loss of $58.0M in FY2024.
Trading 72% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Lucid Diagnostics Inc..

Write a review

Newsroom

News about Lucid Diagnostics Inc.

Oil Above $100 Puts Penny Stocks in Focus GlobeNewswire Inc. · 2026-10-23 · positive Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 Benzinga · 2026-03-12 · neutral PAVmed Announces Reverse Stock Split Benzinga · 2025-12-30 · negative Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 Benzinga · 2025-10-29 · neutral Lucid Diagnostics Announces Proposed Public Offering of Common Stock Benzinga · 2025-09-09 · neutral PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024 Benzinga · 2024-10-31 · positive

News & sentiment via Polygon.io

FAQ

Lucid Diagnostics Inc.: frequently asked questions

Is Lucid Diagnostics Inc. an American company?

Lucid Diagnostics Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Lucid Diagnostics Inc. headquartered?

Lucid Diagnostics Inc. is headquartered in New York, New York, United States.

Is Lucid Diagnostics Inc. publicly traded?

Yes — Lucid Diagnostics Inc. is a publicly traded company. Its stock trades under the ticker symbol LUCD on the NASDAQ.

What does Lucid Diagnostics Inc. do?

Lucid Diagnostics Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore